Moreover, the regulatory frameworks for innovative multi-target therapies are complex, necessitating extensive safety databases including varied patient demographics
For acute injuries, some practitioners recommend up to 500750mcg daily for the first 12 weeks, then reducing to 250500mcg for maintenance
They were controlled clinical observations that appeared in peer-reviewed literature and directly shaped the next decade of melanocortin research
A higher dose of Wegovy (7.2 mg) was approved by the MHRA in January 2026 following the STEP UP trial, which showed: 2 Wegovy 7.2 mg: 20.7% average weight loss Wegovy 2.4 mg: 17.5% average weight loss 50.9% of those on 7.2 mg lost at least 20% of body weight The 7.2 mg dose is not a starting dose
The repeated administration study also revealed effects on metabolic and inflammatory parameters that warrant further investigation
CVS Health has performed well over the past 18 months, after several years of challenges